HSUK:PA:PA-HSBC UK SUS EQ ETF (EUR)

ETF | Others |

Last Closing

USD 20.14

Change

-0.39 (-1.90)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.93%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-7.15 (-1.51%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.66 (-1.38%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.33 (-1.06%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.56 (-0.23%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.45 (-2.11%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.86 (-0.93%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.79 (-1.65%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.57%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.60 (-0.80%)

USD 5.54B

ETFs Containing HSUK:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.49% 56% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.49% 56% F 50% F
Trailing 12 Months  
Capital Gain -0.64% 66% D+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.64% 64% D 66% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.88% 44% F 56% F
Dividend Return 6.88% 43% F 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.84% 72% C 92% A
Risk Adjusted Return 87.75% 64% D 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.